XML 91 R80.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Stock Compensation - RRP Stock Options (Details) - Recognition and Retention Plan [Member] - USD ($)
12 Months Ended
Nov. 16, 2011
Nov. 17, 2010
Dec. 21, 2008
Nov. 21, 2006
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Outstanding at beginning of year (in shares)         32,491 92,667  
Outstanding at beginning of year, weighted average exercise price (in dollars per share)         $ 4.98 $ 10.46  
Outstanding, weighted average remaining contractual term (Year)         2 years 335 days 3 years 357 days 2 years 36 days
Outstanding, aggregate intrinsic value         $ 285,522 $ 251,702  
Forfeited (in shares)         (17,443)  
Forfeited, weighted average exercise price (in dollars per share)         $ 12.35  
Granted (in shares) 13,083 8,722 5,451 92,666 0 0  
Granted, weighted average exercise price (in dollars per share) $ 4.25 $ 6 $ 9.90 $ 12.35 $ 0 $ 0  
Exercised (in shares)         (2,000) (57,181)  
Exercised, weighted average exercise price (in dollars per share)         $ 3.57 $ 10.36  
Exercised, aggregate intrinsic value         $ 20,280 $ 135,519  
Outstanding at end of year (in shares)         30,491 32,491 92,667
Outstanding at end of year, weighted average exercise price (in dollars per share)         $ 5.08 $ 4.98 $ 10.46
Exercisable at year end (in shares)         30,491 32,491  
Exercisable at year end, weighted average exercise price (in dollars per share)         $ 5.08 $ 4.98  
Exercisable at year end, weighted average remaining contractual term (Year)         2 years 335 days 3 years 357 days  
Exercisable at year end, aggregate intrinsic value         $ 285,522 $ 251,702  
Conversion for stock offering (in shares) [1]           14,448  
Conversion for stock offering, weighted average exercise price (in dollars per share) [1]           $ 7.36  
Conversion for stock offering , weighted average remaining contractual term (Year) [1]           2 years 135 days  
Forfeited, weighted average remaining contractual term (Year)           324 days  
[1] Non-vested shares and weighted average grant date fair value were adjusted at the 1.1921 exchange ratio upon closing of the stock conversion as discussed in Note 1.